JAMIE SHOWALTER: Open Payments
NPI 1063715936 · BEDFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,711 in 140 payments from 14 companies in 2025. Trend: 2023 $1,488 · 2024 $2,138 · 2025 $2,711
Food & beverage: $2,611Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $643 |
| Otsuka America Pharmaceutical, Inc. | 22 | $381 |
| Janssen Pharmaceuticals, Inc | 21 | $356 |
| Teva Pharmaceuticals USA, Inc. | 14 | $332 |
| Alkermes, Inc. | 13 | $298 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $280 |
| E.R. Squibb & Sons, L.L.C. | 7 | $121 |
| Lundbeck LLC | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 3 | $60 |
Products named: VRAYLAR, ARISTADA, CAPLYTA, REXULTI, INVEGA SUSTENNA, SPRAVATO, COBENFY, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
